NBEO® Part 1 Full Length Test #1 - Immunology
Next
0 of 4 questions completed
Questions:
- 1
- 2
- 3
- 4
Information
|
Optometry Board Practice Test for the NBEO® Part 1 Test #1 – Immunology This test is comprised of 4 items, which must be completed within 4 minutes. |
You have already completed the quiz before. Hence you can not start it again.
Exam is loading ...
You must sign in or sign up to start the exam.
You have to finish following exam, to start this exam:
Results
0 of 4 questions answered correctly
Your time:
Time has elapsed
You answered 0 of 0 (0) questions correct
| Average score |
|
| Your score |
|
Categories
- Biochemistry 0%
- General Pharmacology: Anti-Inflammatory Drugs 0%
- General Pharmacology: Anticoagulants 0%
- General Pharmacology: Antidepressants 0%
- General Pharmacology: Antifungal Drugs 0%
- General Pharmacology: Antihistamine Drugs 0%
- General Pharmacology: Antimicrobial Drugs 0%
- General Pharmacology: Autonomic drugs 0%
- General Pharmacology: Cardiovascular Drugs 0%
- General Pharmacology: CNS Drugs 0%
- General Pharmacology: Diabetes Drugs 0%
- General Pharmacology: Drugs of Abuse 0%
- General Pharmacology: Endocrine Drugs 0%
- General Pharmacology: Gastrointestinal Drugs 0%
- General Pharmacology: Genitourinary Drugs 0%
- General Pharmacology: Hypertensive Drugs 0%
- General Pharmacology: Respiratory Drugs 0%
- General Pharmacology: Tuberculosis Drugs 0%
- Gross Anatomy: Blood Supply 0%
- Gross Anatomy: Brain/Nervous System 0%
- Gross Anatomy: Lymphatics 0%
- Gross Physiology: Kidney 0%
- Gross Physiology: Pancreas 0%
- Histology + Ocular Anatomy 0%
- Immunology + Systemic Disease: Immunopathology 0%
- Immunology: Systemic Health 0%
- Microbiology 0%
- Neuroanatomy 0%
- Neuroscience: Neuroanatomy 0%
- Ocular Anatomy: Adnexa/Orbit 0%
- Ocular Anatomy: Conjunctiva + Orbit 0%
- Ocular Anatomy: Cornea 0%
- Ocular Anatomy: Eyelid 0%
- Ocular Anatomy: Iris 0%
- Ocular Anatomy: Lens 0%
- Ocular Anatomy: Ocular and Orbital Nerves 0%
- Ocular Anatomy: Optic Nerve 0%
- Ocular Anatomy: Orbit 0%
- Ocular Anatomy: Orbit/Blood Supply 0%
- Ocular Anatomy: Orbit/Extraocular Muscles 0%
- Ocular Anatomy: Retina 0%
- Ocular Anatomy: Uvea 0%
- Ocular Anatomy: Vitreous 0%
- Ocular and General Pharmacology 0%
- Ocular and General Pharmacology: CNS Drugs 0%
- Ocular Disease: Conjunctiva 0%
- Ocular Disease: Cornea 0%
- Ocular Disease: Cornea/Refractive Surgery 0%
- Ocular Disease: Episclera/Sclera/Anterior and Posterior Uvea 0%
- Ocular Disease: Glaucoma 0%
- Ocular Disease: Lens/Cataract/IOL Pre- and Post-op Care 0%
- Ocular Disease: Lids/Lashes/Lacrimal System 0%
- Ocular Disease: Neuro-Ophthalmic Disorder 0%
- Ocular Disease: Ocular Adnexa/Orbit/External Disease 0%
- Ocular Disease: Ocular Adnexa/Orbit/External Disease + Retina 0%
- Ocular Disease: Retina/Choroid 0%
- Ocular Disease: Trauma 0%
- Ocular Embryology and Development 0%
- Ocular Motility + Binocular Vision 0%
- Ocular Motility + Binocular Vision: Accommodation 0%
- Ocular Motility + Binocular Vision: Amblyopia 0%
- Ocular Motility + Binocular Vision: Ametropia 0%
- Ocular Motility + Binocular Vision: Fixation Disparity 0%
- Ocular Motility + Binocular Vision: Ocular Development 0%
- Ocular Motility + Binocular Vision: Ocular Motor Dysfunction 0%
- Ocular Motility + Binocular Vision: Vergence/OMD 0%
- Ocular Pharmacology 0%
- Ocular Pharmacology: Agents for Exudative ARMD 0%
- Ocular Pharmacology: Anti-Inflammatory Agents 0%
- Ocular Pharmacology: Anti-Inflammatory Drugs 0%
- Ocular Pharmacology: Antihistamines 0%
- Ocular Pharmacology: Antimicrobial Drugs 0%
- Ocular Pharmacology: Autonomic Drugs 0%
- Ocular Pharmacology: Glaucoma Agents 0%
- Ocular Pharmacology: Glaucoma Drugs 0%
- Ocular Pharmacology: Hyperosmotic Agents 0%
- Ocular Pharmacology: Preservatives 0%
- Ocular Pharmacology: Topical Anesthetics Drugs 0%
- Ocular Pharmacology: Topical Ocular Anesthetics 0%
- Ocular Pharmacology: Tuberculosis Drugs 0%
- Ocular Physiology: Aqueous 0%
- Ocular Physiology: Aqueous 0%
- Ocular Physiology: Cornea 0%
- Ocular Physiology: Neuroanatomy 0%
- Ocular Physiology: Tears 0%
- Ophthalmic Optics 0%
- Ophthalmic Optics: Lasers 0%
- Optics: Contact Lenses 0%
- Optics: Low Vision 0%
- Systemic Disease: Autoimmune Disease 0%
- Systemic Disease: Demyelinating Disease 0%
- Systemic Disease: Diseases of Reproductive System 0%
- Systemic Disease: Endocrine System 0%
- Systemic Disease: Gastrointestinal System 0%
- Systemic Disease: Genetic Disease 0%
- Systemic Disease: Genetic Disorder 0%
- Systemic Disease: Genetic Disorders 0%
- Systemic Disease: Immunopathology 0%
- Systemic Disease: Inflammatory Disease 0%
- Systemic Disease: Integumentary System 0%
- Systemic Disease: Neuroanatomy 0%
- Systemic Disease: Neurodegenerative Disease 0%
- Systemic Disease: Vascular Disease 0%
- Systemic Disease: Vascular Disease/Neuroanatomy 0%
- Systemic Disease: Vasculitis Disorders 0%
- Visual Perception 0%
-
Based on your performance on this Optometry Board Part 1 Practice Test, you’re not yet ready for the NBEO® Part 1.
Keep your head up! Also, don’t focus on your estimated score, they mean essentially nothing at the start. Rarely does anyone start these exams and score well immediately, if that was the case then they wouldn’t even need to practice! These are ‘practice’ tests, meaning you’re practicing to improve your skills. If you continue to work hard and study, read and understand the solutions, practice with “OptometryBoards.com” daily and give it your best effort, we promise your score will improve. Review and learn for now, and the scores will come.
-The “OptometryBoards.com” Team
-
Congratulations! Based on your performance on this Optometry Board Part 1 Practice Test, you’re predicted to pass your NBEO® Part 1! Keep hammering away at our Optometry Board questions so that you can keep up the great work!
-The “OptometryBoards.com” Team
-
Question 1 of 4
1. Question
The presence of which immunoglobulin may cause complications during pregnancy?
CorrectD. IgG is able to cross into the maternal placenta and attack the fetal cells. IgA is the main immune component found in tears. IgE is involved in Type 1 Hypersensitivity reactions which cause the degranulation of mast cells. IgD is found on the plasma membranes of immature B-cells. IgM is the first antibody produced in response to a novel antigen. It is the largest and is capable of producing IgG.
IncorrectD. IgG is able to cross into the maternal placenta and attack the fetal cells. IgA is the main immune component found in tears. IgE is involved in Type 1 Hypersensitivity reactions which cause the degranulation of mast cells. IgD is found on the plasma membranes of immature B-cells. IgM is the first antibody produced in response to a novel antigen. It is the largest and is capable of producing IgG.
-
Question 2 of 4
2. Question
Which of the following cells does NOT require an antigen presenting cell when responding to antigens?
CorrectA. Natural Killer cells do not require an antigen presenting cell to attack antigens. NK cells serve as the rapid response team for antigens that have yet to be phagocytosed. The remaining cells are part of a specific immunity response.
IncorrectA. Natural Killer cells do not require an antigen presenting cell to attack antigens. NK cells serve as the rapid response team for antigens that have yet to be phagocytosed. The remaining cells are part of a specific immunity response.
-
Question 3 of 4
3. Question
Which of the following mediators is released by helper T cells in order to promote further growth and differentiation of T cells?
CorrectD. Interleukin 2 is released by helper T cells in response to antigen binding. This release, paired with binding of helper T cells to Class II MHC, stimulates the production of more immune factors.
IncorrectD. Interleukin 2 is released by helper T cells in response to antigen binding. This release, paired with binding of helper T cells to Class II MHC, stimulates the production of more immune factors.
-
Question 4 of 4
4. Question
_________ is the process by which complement proteins bind to an antigen to trigger phagocytosis of the cell.
CorrectB. Opsonization is the process by which complement proteins cover an antigen to initiate the immune system. Opsons alert the immune system to phagocytose the target cell.
IncorrectB. Opsonization is the process by which complement proteins cover an antigen to initiate the immune system. Opsons alert the immune system to phagocytose the target cell.
- 1
- 2
- 3
- 4
- Answered
- Review